Athira Pharma Stock Forward View - Simple Moving Average
| ATHADelisted Stock | USD 4.62 0.12 2.53% |
Athira Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Athira Pharma stock prices and determine the direction of Athira Pharma's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Athira Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, the value of RSI of Athira Pharma's share price is approaching 40. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Athira Pharma, making its price go up or down. Momentum 40
Sell Extended
Oversold | Overbought |
Using Athira Pharma hype-based prediction, you can estimate the value of Athira Pharma from the perspective of Athira Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Athira Pharma on the next trading day is expected to be 4.62 with a mean absolute deviation of 0.28 and the sum of the absolute errors of 16.58. Athira Pharma after-hype prediction price | USD 4.38 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Athira |
Athira Pharma Additional Predictive Modules
Most predictive techniques to examine Athira price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Athira using various technical indicators. When you analyze Athira charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Athira Pharma Simple Moving Average Price Forecast For the 4th of February
Given 90 days horizon, the Simple Moving Average forecasted value of Athira Pharma on the next trading day is expected to be 4.62 with a mean absolute deviation of 0.28, mean absolute percentage error of 0.24, and the sum of the absolute errors of 16.58.Please note that although there have been many attempts to predict Athira Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Athira Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Athira Pharma Stock Forecast Pattern
| Backtest Athira Pharma | Athira Pharma Price Prediction | Research Analysis |
Athira Pharma Forecasted Value
In the context of forecasting Athira Pharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Athira Pharma's downside and upside margins for the forecasting period are 0.05 and 13.95, respectively. We have considered Athira Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Athira Pharma stock data series using in forecasting. Note that when a statistical model is used to represent Athira Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.8396 |
| Bias | Arithmetic mean of the errors | -0.01 |
| MAD | Mean absolute deviation | 0.2763 |
| MAPE | Mean absolute percentage error | 0.0483 |
| SAE | Sum of the absolute errors | 16.58 |
Predictive Modules for Athira Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Athira Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Athira Pharma After-Hype Price Density Analysis
As far as predicting the price of Athira Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Athira Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Athira Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Athira Pharma Estimiated After-Hype Price Volatility
In the context of predicting Athira Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Athira Pharma's historical news coverage. Athira Pharma's after-hype downside and upside margins for the prediction period are 0.22 and 13.63, respectively. We have considered Athira Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Athira Pharma is very risky at this time. Analysis and calculation of next after-hype price of Athira Pharma is based on 3 months time horizon.
Athira Pharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Athira Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Athira Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Athira Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.50 | 9.33 | 0.27 | 0.06 | 8 Events / Month | 7 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.62 | 4.38 | 5.19 |
|
Athira Pharma Hype Timeline
Athira Pharma is presently traded for 4.62. The entity has historical hype elasticity of -0.27, and average elasticity to hype of competition of -0.06. Athira is forecasted to decline in value after the next headline, with the price expected to drop to 4.38. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -5.19%, whereas the daily expected return is presently at 0.5%. The volatility of related hype on Athira Pharma is about 8256.64%, with the expected price after the next announcement by competition of 4.56. About 13.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.99. Some equities with similar Price to Book (P/B) outperform the market in the long run. Athira Pharma recorded a loss per share of 9.67. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 18th of September 2025. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Historical Fundamental Analysis of Athira Pharma to cross-verify your projections.Athira Pharma Related Hype Analysis
Having access to credible news sources related to Athira Pharma's direct competition is more important than ever and may enhance your ability to predict Athira Pharma's future price movements. Getting to know how Athira Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Athira Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| LPTX | Leap Therapeutics | 0.01 | 9 per month | 6.90 | 0.14 | 25.00 | (9.43) | 65.13 | |
| CTXR | Citius Pharmaceuticals | 0.1 | 9 per month | 0.00 | (0.14) | 10.59 | (9.49) | 38.23 | |
| ICU | SeaStar Medical Holding | 0.03 | 9 per month | 0.00 | (0.15) | 9.58 | (9.88) | 34.66 | |
| APLM | Apollomics Class A | (0.72) | 2 per month | 8.97 | 0.05 | 17.50 | (14.50) | 44.38 | |
| MBRX | Moleculin Biotech | (0.50) | 9 per month | 0.00 | (0.21) | 9.37 | (11.73) | 41.63 | |
| CRIS | Curis Inc | (0.11) | 8 per month | 0.00 | (0.14) | 9.60 | (8.13) | 33.70 | |
| FBLG | FibroBiologics Common Stock | (0.01) | 9 per month | 0.00 | (0.02) | 14.71 | (15.15) | 47.13 | |
| LNAI | Lunai Bioworks | 0.05 | 8 per month | 0.00 | (0.02) | 12.62 | (8.82) | 55.92 | |
| ADTX | Aditxt Inc | 0.10 | 20 per month | 0.00 | (0.23) | 22.54 | (26.33) | 63.67 | |
| DARE | Dare Bioscience | (0.08) | 9 per month | 0.00 | (0.03) | 6.55 | (6.98) | 26.52 |
Other Forecasting Options for Athira Pharma
For every potential investor in Athira, whether a beginner or expert, Athira Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Athira Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Athira. Basic forecasting techniques help filter out the noise by identifying Athira Pharma's price trends.Athira Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Athira Pharma stock to make a market-neutral strategy. Peer analysis of Athira Pharma could also be used in its relative valuation, which is a method of valuing Athira Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Athira Pharma Market Strength Events
Market strength indicators help investors to evaluate how Athira Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Athira Pharma shares will generate the highest return on investment. By undertsting and applying Athira Pharma stock market strength indicators, traders can identify Athira Pharma entry and exit signals to maximize returns.
Athira Pharma Risk Indicators
The analysis of Athira Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Athira Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting athira stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.14 | |||
| Semi Deviation | 4.13 | |||
| Standard Deviation | 8.9 | |||
| Variance | 79.29 | |||
| Downside Variance | 20.41 | |||
| Semi Variance | 17.06 | |||
| Expected Short fall | (4.91) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Athira Pharma
The number of cover stories for Athira Pharma depends on current market conditions and Athira Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Athira Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Athira Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Athira Pharma Short Properties
Athira Pharma's future price predictability will typically decrease when Athira Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Athira Pharma often depends not only on the future outlook of the potential Athira Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Athira Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.8 M | |
| Cash And Short Term Investments | 51.3 M |
Check out Historical Fundamental Analysis of Athira Pharma to cross-verify your projections. You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Athira Stock
If you are still planning to invest in Athira Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Athira Pharma's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |